Behrmed
The computed 12-month bankruptcy probability of Behrmed is 0.1% (very low). The 2025 annual accounts show equity of €205k and a net result of €91k. Equity is growing by ~14.9% per year across the filed fiscal years. Its solvency ranks better than 95% of 2204 sector peers (fiscal year 2025). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €205k |
| Net result | €91k |
| Better than sector | 95% |
| Active | 9 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 99.2% | 58.0% | |
| Net result | €91k | €60k | |
| Equity | €205k | €74k | |
| Gross operating margin | €117k | €96k | |
| Total assets | €206k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €116k |
| Net profit | €91k |
| Cash flow | €93k |
| Staff costs | - |
| Income taxes | €24k |
| Dividends | €35k |
| Total assets | €206k |
| Equity | €205k |
| Debt | €2k |
| of which ≤ 1y | €2k |
| of which > 1y | - |
| Working capital | €198k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 130.53 |
| Quick ratio | 130.53 |
| Working capital ratio | 95.9% |
| Solvency | 99.2% |
| Debt / equity | 0.01 |
| Long-term debt ratio | - |
| Interest coverage | 1542.59 |
| Gross margin | - |
| Net margin | - |
| ROA | 44.1% |
| ROE | 44.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €206k |
| Fixed assets | 21/28 | €7k |
| Tangible fixed assets | 22/27 | €7k |
| Current assets | 29/58 | €200k |
| Amounts receivable within one year | 40/41 | €21k |
| Investments | 50/53 | €86k |
| Cash & bank | 54/58 | €89k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €206k |
| Equity | 10/15 | €205k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €2k |
| Accumulated profits (losses) | 14 | €184k |
| Amounts payable | 17/49 | €2k |
| Amounts payable within one year | 42/48 | €2k |
| Trade debts payable within one year | 44 | €488 |
| Income statement | ||
| Gross operating margin | 9900 | €117k |
| Operating result | 9901 | €115k |
| Financial income | 75 | €965 |
| Financial charges | 65 | €75 |
| Result before taxes | 9903 | €115k |
| Income taxes | 67/77 | €24k |
| Net result for the period | 9904 | €91k |
| Result to be appropriated | 9905 | €91k |
| NACE primary | Human health(86101) |
| Legal form | Private limited company(610) |
| Incorporation | 12-05-2017 |
| Status | Active |
| Postal code | 1000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21811M2039/00B000 | Brussels | 175 m² | 1 · 185 m² | 20.9 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
04-12-2023 Discharge granted to the board
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "bijzondere_gevolmachtigde",
"person": {
"rrn": null,
"name": "Filip Van Bever",
"address": "Justus Lupsiusplein 18, 3090 Overijse",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "De algemene vergadering beslist Filip Van Bever, Justus Lupsiusplein 18, 3090 Overijse als bijzondere gevolmachtigde met macht van indeplaatsstelling aan te stellen teneinde al het nodige te doen bij de Kruispuntbank Ondernemingen (K.B.O.), bij het rechtspersonenregister, bij het ondernemingsloket, ",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_pending",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "KREPS Bernard Patrick Una",
"address": "1000 Brussel, Zinnikstraat 13",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "De algemene vergadering zal op de volgende jaarvergadering beslissen over de kwijting aan de ontslagnemende zaakvoerder voor de uitoefening van zijn mandaat.",
"decharge_status": "pending_next_agm",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Henri VAN EECKHOUDT",
"firm_city": null,
"firm_name": null,
"office_city": "Lennik",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-12-04",
"filing_date": "2023-11-30",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-10-13",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0675.805.730",
"name_full": "Behrmed",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Henri VAN EECKHOUDT",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"uitgifte van akte"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Behrmed |